• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康儿童与炎症性肠病和/或自身免疫性肝病患儿肠道微生物群特征的差异:一项病例对照研究。

Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study.

作者信息

Lopez Robert N, Leach Steven T, Bowcock Nerissa, Coker Elise, Shapiro Amanda J, Day Andrew S, Lemberg Daniel A

机构信息

Department of Gastroenterology, Sydney Children's Hospital, Sydney 2031, Australia.

Department of Paediatrics, School of Clinical Medicine, University of NSW, Sydney 2052, Australia.

出版信息

Pathogens. 2023 Apr 12;12(4):585. doi: 10.3390/pathogens12040585.

DOI:10.3390/pathogens12040585
PMID:37111471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10145405/
Abstract

BACKGROUND

The role of gastrointestinal microbiome in health and disease is increasingly appreciated. A significant amount of evidence clearly points to a dysbiosis manifest in inflammatory bowel disease (IBD) when compared to healthy controls. Less understood is the microbiome profile in autoimmune liver disease (AILD). Both adult and paediatric data indicate a distinct microbial signature in patients with IBD and co-existent primary sclerosing cholangitis (PSC), which is unique and different compared to the microbial signature that exists in patients with IBD alone. However, there is limited information on the microbiome make-up of patients with parenchymal liver disease, with or without IBD.

METHODS

The present study sought to compare the microbiome of children with IBD, to those with IBD-AILD, those with AILD alone and those of healthy controls.

RESULTS

Results from this work indicate that children with AILD have a microbiome profile that mirrors healthy controls.

CONCLUSION

Those with IBD-AILD and IBD have similar microbiome profiles which are distinct from AILD alone and healthy controls. This suggests that the dysbiosis in these groups is primarily due to IBD rather than AILD.

摘要

背景

胃肠道微生物群在健康和疾病中的作用越来越受到重视。大量证据清楚地表明,与健康对照相比,炎症性肠病(IBD)中存在微生物群落失调。自身免疫性肝病(AILD)中的微生物群特征则了解较少。成人和儿科数据均表明,IBD合并原发性硬化性胆管炎(PSC)患者具有独特的微生物特征,与仅患有IBD的患者的微生物特征相比是独特且不同的。然而,关于有或没有IBD的实质性肝病患者的微生物群组成的信息有限。

方法

本研究旨在比较IBD儿童、IBD-AILD儿童、单纯AILD儿童和健康对照儿童的微生物群。

结果

这项研究的结果表明,AILD儿童的微生物群特征与健康对照相似。

结论

IBD-AILD患者和IBD患者具有相似的微生物群特征,这与单纯AILD患者和健康对照不同。这表明这些组中的微生物群落失调主要是由于IBD而非AILD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/b1bc8366cb75/pathogens-12-00585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/ef54f20b0cc3/pathogens-12-00585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/e17e528269bf/pathogens-12-00585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/b1bc8366cb75/pathogens-12-00585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/ef54f20b0cc3/pathogens-12-00585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/e17e528269bf/pathogens-12-00585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/10145405/b1bc8366cb75/pathogens-12-00585-g003.jpg

相似文献

1
Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study.健康儿童与炎症性肠病和/或自身免疫性肝病患儿肠道微生物群特征的差异:一项病例对照研究。
Pathogens. 2023 Apr 12;12(4):585. doi: 10.3390/pathogens12040585.
2
Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.炎症性肠病相关自身免疫性肝病患者的临床特征和预后。
Gastroenterol Hepatol. 2022 Feb;45(2):83-90. doi: 10.1016/j.gastrohep.2021.03.011. Epub 2021 May 20.
3
Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者唾液和粪便微生物组的改变。
Hepatol Int. 2021 Feb;15(1):191-201. doi: 10.1007/s12072-020-10089-z. Epub 2020 Sep 19.
4
Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.原发性硬化性胆管炎患者与炎症性肠病和健康对照者的肠道微生物组特征比较。
Mol Biol Rep. 2021 Jul;48(7):5519-5529. doi: 10.1007/s11033-021-06567-8. Epub 2021 Jul 25.
5
Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.小儿自身免疫性肝病的实践演变和表型变化:来自澳大利亚中心的结果。
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):80-85. doi: 10.1097/MPG.0000000000001927.
6
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.原发性硬化性胆管炎中基本营养素的肠道微生物代谢改变。
Gastroenterology. 2021 Apr;160(5):1784-1798.e0. doi: 10.1053/j.gastro.2020.12.058. Epub 2020 Dec 31.
7
Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile.与原发性硬化性胆管炎相关的炎症性肠病与肠道微生物群和胆汁酸谱的改变有关。
J Crohns Colitis. 2024 Jul 9;18(12):1957-66. doi: 10.1093/ecco-jcc/jjae096.
8
Gut microbiome in primary sclerosing cholangitis: A review.原发性硬化性胆管炎的肠道微生物组:综述。
World J Gastroenterol. 2020 Jun 7;26(21):2768-2780. doi: 10.3748/wjg.v26.i21.2768.
9
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.原发性硬化性胆管炎和溃疡性结肠炎患者不同的肠道微生物群特征。
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.
10
Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.原发性硬化性胆管炎-炎症性肠病中共同克隆起源的肠道和肝脏 T 细胞。
J Hepatol. 2017 Jan;66(1):116-122. doi: 10.1016/j.jhep.2016.09.002. Epub 2016 Sep 17.

本文引用的文献

1
The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes.自身免疫性肝病中的微生物组:宏基因组学和代谢组学变化
Front Physiol. 2021 Oct 8;12:715852. doi: 10.3389/fphys.2021.715852. eCollection 2021.
2
Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.原发性硬化性胆管炎合并溃疡性结肠炎患儿和青少年的肠道微生物组。
Front Immunol. 2021 Feb 5;11:598152. doi: 10.3389/fimmu.2020.598152. eCollection 2020.
3
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals.
粪便微生物群可区分自身免疫性肝炎患者与健康个体。
Front Cell Infect Microbiol. 2020 Aug 3;10:342. doi: 10.3389/fcimb.2020.00342. eCollection 2020.
4
Gut microbiome in primary sclerosing cholangitis: A review.原发性硬化性胆管炎的肠道微生物组:综述。
World J Gastroenterol. 2020 Jun 7;26(21):2768-2780. doi: 10.3748/wjg.v26.i21.2768.
5
Human microbiome: an academic update on human body site specific surveillance and its possible role.人类微生物组:人体特定部位监测及其可能作用的学术更新
Arch Microbiol. 2020 Oct;202(8):2147-2167. doi: 10.1007/s00203-020-01931-x. Epub 2020 Jun 10.
6
Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration.健康人类胃肠道微生物组:经过十年探索后的组成和功能。
Dig Dis Sci. 2020 Mar;65(3):695-705. doi: 10.1007/s10620-020-06118-4.
7
Alterations of gut microbiome in autoimmune hepatitis.自身免疫性肝炎中肠道微生物组的改变。
Gut. 2020 Mar;69(3):569-577. doi: 10.1136/gutjnl-2018-317836. Epub 2019 Jun 14.
8
Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement.儿童自身免疫性肝病的诊断与管理:欧洲儿科胃肠病、肝病和营养学会肝病委员会立场声明
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):345-360. doi: 10.1097/MPG.0000000000001801.
9
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.原发性硬化性胆管炎 781 例儿童自然史:多中心国际协作研究。
Hepatology. 2017 Aug;66(2):518-527. doi: 10.1002/hep.29204. Epub 2017 Jun 26.
10
Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.日本儿童期起病的原发性硬化性胆管炎患者粪便微生物群的特征分析。
Gut. 2017 Jul;66(7):1344-1346. doi: 10.1136/gutjnl-2016-312533. Epub 2016 Sep 26.